Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Thursday, January 13, 2022

Lucintel Forecasts AI in the Global Drug Discovery Market to Grow at a CAGR of 39% to 41% from 2021 to 2026

According to the recent study the AI in the Global Drug Discovery Market is projected to grow at a CAGR of 39% to 41% from 2021 to 2026. Growth in this market is primarily driven by growing pharmaceutical industry, high demand for personalized drug, rising adoption of cloud-based technologys & services, growing number of cross-industry collaborations and partnerships, and increasing awareness of AI among drug manufacturers.

Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in AI in the global drug discovery market by offering (software, services), drug type (small molecule, large molecules), technology (machine learning (deep learning, supervised learning, reinforcement learning, unsupervised learning, and others) and others technologies), application (immuno-oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, and others), end user industry (pharmaceutical & biotechnology companies, contract research organizations, and research centers and academic & government institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/ai-artificial-intelligence-in-the-global-drug-discovery-market.aspx

“Machine learning market is expected to remain the largest segment during the forecast period.”

Based on technology, the AI in the global drug discovery market is segmented into machine learning, deep learning, supervised learning, reinforcement learning, unsupervised learning, and others. Lucintel forecasts that the machine learning market is expected to remain the largest segment due to capability to collect and handle big data and demand to improve productivity in many end use industries.

“Within the AI in the global drug discovery market, the pharmaceutical & bioend use industry companies segment is expected to remain the largest end use industry.”

Based on end use industry the pharmaceutical & bioend use industry companies segment is expected to witness the highest growth over the forecast period due to high adoption of AI in the pharmaceutical industry, AI’s high accuracy to identify drug’s molecule binding properties, and increasing demand for drugs for complex conditions.

“North America will dominate the AI in the global drug discovery market in near future.”

North America will remain the largest region during the forecast period due to high adoption of AI systems, growing pharmaceutical industry, and a large presence of AI manufacturers and the consumer market.

Download Brochure of this report by clicking on https://www.lucintel.com/ai-artificial-intelligence-in-the-global-drug-discovery-market.aspx

Major players of AI in the global drug discovery market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. IBM, Microsoft, Google, NVIDIA, Atomwise, Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR , OWKIN, XtalPi, Verge Genomics, and BERG are among the major AI in the global drug discovery providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/ai-artificial-intelligence-in-the-global-drug-discovery-market.aspx or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Semiconductor Market:

For more details click here https://www.lucintel.com/semiconductor-market.aspx

 

Fire Suppression Market:

For more details click here https://www.lucintel.com/fire-suppression-market.aspx

 

Mobile Health and Fitness Sensor Market:

For more details click here https://www.lucintel.com/mobile-health-and-fitness-sensor-market.aspx

 

High Purity Quartz Market:

For more details click here https://www.lucintel.com/high-purity-quartz-market.aspx

 

Bluetooth Low Energy IC Market:

For more details click here https://www.lucintel.com/bluetooth-low-energy-ic-market.aspx

 

Metal Terminal MLCC Market:

For more details click here https://www.lucintel.com/metal-terminal-mlcc-market.aspx

 

Building Information Modeling Market:

For more details click here https://www.lucintel.com/building-information-modeling-market.aspx

 

Energy Harvesting System Market:

For more details click here https://www.lucintel.com/energy-harvesting-system-market.aspx

 

Multilayer Ceramic Capacitor Market:

For more details click here https://www.lucintel.com/multilayer-ceramic-capacitor-market.aspx

 

Printed Circuit Board (PCB) Market:

For more details click here https://www.lucintel.com/pcb-markets.aspx

No comments:

Post a Comment